跳至主要内容
临床试验/CTRI/2021/10/037416
CTRI/2021/10/037416尚未招募2 期

Subconjunctival injection of Bevacizumab (Anti VEGF) for Corneal Neovascularisation,after Penetrating Keratoplasty, A Prospective,Open Label,Non Comparative study

SNMedical College0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1)patients having 2 or more than 2 quadrant corneal neovascularisation
  • 2)patients who developed corneal neovascularisation during F/U ,not responding to conventional medical treatment .
  • 3)patients who gave consent to be in follow up.

排除标准

  • 1)patients having persistent epithelial defect
  • 2)patients who were systemically not fit for subconj Bevacizumab injection;pts with H/O recent attack of M.I.,stroke and uncontrolled Hypertension.
  • 3)pregnant female

研究者

发起方
SNMedical College

相似试验